Skip to content
Biodatica
Start free

VINDHYA DATA SCIENCE INC.

MORRISVILLE, NC

OncologyGrant-only
Compare Sign in to watch

What changed

NIH R43 · $0.2M · BIOCLIN: A precision medicine platform to support biomarker-driven clinical trials

Jun 2025Grant renewalJun 11, 2025Source filing (opens the source filing in a new tab)

Momentum

28no change

Momentum 28 out of 100, unchanged since the last recompute.

Little recent filing activity, or the events on file have decayed.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Grant-only

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Peer position

14,016 pre-ticker oncology companies at Grant-only

Peer ranking — where this company sits among its stage-and-area peers by momentum, and how its runway compares to the peer median — is part of the Analyst tier.

Compare seats

A ranking of the same momentum figure the feed publishes, computed live against public-filing peers. It is a relative position, not a recommendation, and it is identical for every viewer.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

  1. Grant

    R43 · $55k · non-dilutive

    Mar 1, 2025

    VINDHYA DATA SCIENCE INC. · PI REDDY, ANUPAMA · NCATS · award ends Jun 30, 2025 · Developing entrepreneurial skills for the BIOCLIN software platform to support biomarker clinical trials

    NIH RePORTER · NIH RePORTER 11237431 (opens the source filing in a new tab)

  2. Grant

    R43 · $174k · non-dilutive

    Jul 15, 2024

    VINDHYA DATA SCIENCE INC. · PI REDDY, ANUPAMA · NCATS · award ends Jun 30, 2026 · BIOCLIN: A precision medicine platform to support biomarker-driven clinical trials

    NIH RePORTER · NIH RePORTER 11132957 (opens the source filing in a new tab)

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources